PFSW

ValuEngine Downgrades PFSweb (PFSW) to Sell

PFSweb (NASDAQ:PFSW) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Monday, ValuEngine reports. Other research analysts have also recently issued reports about the stock. Craig Hallum cut shares of PFSweb from a “buy” rating to a “hold” rating in a report on Tuesday, March …

ValuEngine Downgrades PFSweb (PFSW) to Sell Read More »

PFSweb (PFSW) versus Protagenic Therapeutics (PTIX) Financial Review

Protagenic Therapeutics (OTCMKTS:PTIX) and PFSweb (NASDAQ:PFSW) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk. Insider and Institutional Ownership 57.7% of PFSweb shares are held by institutional investors. 51.1% of Protagenic …

PFSweb (PFSW) versus Protagenic Therapeutics (PTIX) Financial Review Read More »

PFSweb, Inc. (PFSW) Shares Sold by Deutsche Bank AG

Deutsche Bank AG lessened its holdings in shares of PFSweb, Inc. (NASDAQ:PFSW) by 66.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 43,057 shares of the business services provider’s stock after selling 84,769 shares during the period. Deutsche Bank AG owned approximately 0.22% of PFSweb worth $220,000 …

PFSweb, Inc. (PFSW) Shares Sold by Deutsche Bank AG Read More »

Brokerages Set PFSweb, Inc. (PFSW) Target Price at $9.44

Shares of PFSweb, Inc. (NASDAQ:PFSW) have been assigned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among brokerages …

Brokerages Set PFSweb, Inc. (PFSW) Target Price at $9.44 Read More »